Apoptosis in bone for tissue engineering.
Bone loss due to congenital defects, trauma, improper fracture fixation, metabolic disturbances, infections, or after tumor resection represents a major clinical problem in head and neck surgery. To address these issues, different types of scaffolds, growth factors and cell sources -- alone or in various combinations -- have been applied for development of bioartificial bone tissues. Although these applications have received increasing interest, use of autologous bone grafts is still considered as the gold standard for tissue repair. Despite progress in some areas of tissue regeneration, significant translation into clinical practice has not been achieved. Reasons for this impass include rejection of engineered tissue implants by the immune system, limited blood supply, or morbidity of the donor site. During the process of bone regeneration, approximately 50-70% of osteoblasts undergo apoptosis. Apoptosis is a naturally occurring cell death pathway induced in a variety of cell types and is associated with caspase activation or caspase mediation. It is recognized as an important component of embryogenesis and tissue morphogenesis and, in adult skeletons, it contributes substantially to physiological bone turnover, repair, and regeneration. Intracellular mechanisms are orchestrated by a variety of proteins, the interplay of which seems to vary, depending on the differentiation state of the cell or the current status of the tissue. Closing gaps in current knowledge of the apoptosis of bone and understanding the mechanisms of cell death in tissue engineered bone will improve results in the translation from bench to bedsite. This review aims to provide a broad overview of the current general concepts in apoptosis with a special focus on its regulation in osteoblasts and its significance for bone tissue engineering.
Department of Otolaryngology, Head and Neck Surgery, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany. gregor.bran@hno.ma.uni-heidelberg.de
Gregor M
GM
Bran
Jens
J
Stern-Straeter
Karl
K
Hörmann
Frank
F
Riedel
Ulrich R
UR
Goessler
D000818:Animals; D017209:Apoptosis; D001857:Bone Matrix / Q000166:cytology; D001842:Bone and Bones / Q000166:cytology* / Q000201:enzymology; D020169:Caspases / Q000378:metabolism; D006801:Humans; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D023822:Tissue Engineering / Q000379:methods*
D019253:Proto-Oncogene Proteins c-bcl-2; D020169:Caspases